Literature DB >> 11396538

Influence of inflammatory bowel disease on different dimensions of quality of life.

F Casellas1, J López-Vivancos, X Badia, J Vilaseca, J R Malagelada.   

Abstract

OBJECTIVE: To establish the impairment of different dimensions of quality of life in inflammatory bowel disease (IBD).
DESIGN: Prospective observational study. PARTICIPANTS: 289 patients [160 with ulcerative colitis (UC) and 129 with Crohn's disease (CD)]. MEASURES: Health-related quality of life was assessed by means of the Inflammatory Bowel Disease Questionnaire (IBDQ) and the Psychological General Well Being Index (PGWBI).
RESULTS: In active IBD, all dimensions of the quality of life scored significantly lower than in inactive IBD, indicating a poor quality of life. Social impairment was the least impaired dimension of the IBDQ in active UC and CD, compared with digestive and systemic symptoms. In inactive IBD, the systemic symptoms domain received the lowest score (P < 0.01). In a subgroup of 22 patients studied before and after remission, emotional function was the most impaired dimension after achieving remission. The Psychological General Well Being Index was significantly impaired in active UC [78.5 (range 64-89)] and CD [76.5 (range 69-97)] relative inactive IBD [104 (range 93-111)] vs 106 (95-113), respectively; P < 0.05].
CONCLUSIONS: Quality of life is impaired in IBD. During relapse, clinicians should pay attention to digestive symptoms and psychological distress. In remission, they should be sensitive to systemic symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11396538     DOI: 10.1097/00042737-200105000-00017

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  35 in total

1.  Factors affecting health related quality of life of patients with inflammatory bowel disease.

Authors:  Francesc Casellas; Josefa López-Vivancos; Alfonso Casado; Juan-Ramon Malagelada
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 3.  Timing of surgery in Crohn's disease: a key issue in the management.

Authors:  Rafael Alós; Joaquín Hinojosa
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

4.  A new look at a mainstay ulcerative colitis therapy.

Authors:  Charles A Sninsky; Michael Safdi; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

Review 5.  The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review.

Authors:  David N Floyd; Sue Langham; Hélène Chevrou Séverac; Barrett G Levesque
Journal:  Dig Dis Sci       Date:  2014-09-26       Impact factor: 3.199

6.  Impact of pain on health-related quality of life in patients with inflammatory bowel disease.

Authors:  Anja Schirbel; Anne Reichert; Stephanie Roll; Daniel C Baumgart; Carsten Büning; Bianca Wittig; Bertram Wiedenmann; Axel Dignass; Andreas Sturm
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

7.  Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.

Authors:  Gregory W Munson; Kenneth A Wallston; Robert S Dittus; Theodore Speroff; Christianne L Roumie
Journal:  J Gen Intern Med       Date:  2009-05-15       Impact factor: 5.128

8.  The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.

Authors:  Guillermo Bastida; Pilar Nos; Mariam Aguas; Belén Beltrán; Marisa Iborra; Vicente Ortiz; Vicente Garrigues; Rafael Estevan; Julio Ponce
Journal:  BMC Gastroenterol       Date:  2010-03-02       Impact factor: 3.067

9.  Beyond standard quality of life measures: the subjective experiences of living with inflammatory bowel disease.

Authors:  Barat J Wolfe; Fuschia M Sirois
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

10.  Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.

Authors:  Daniel B Zandman; Mark A Peppercorn
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.